Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional status

References

• Socie G, Ritz J. Current issues in chronic graft-versus-host disease. Blood. 2014;124:374–384.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Flowers ME. Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program. 2008;134–141.
   PubMedGoogle Scholar
• Jacobsohn DA, Kurland BF, Pidala J, et al. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the chronic GVHD consortium. Blood. 2012;120:2545–2552.
   PubMed Web of Science ®Google Scholar
• Lee SJ. Classification systems for chronic graft-versus-host disease. Blood. 2017;129:30–37.
   PubMed Web of Science ®Google Scholar
• Dignan FL, Amrolia P, Clark A, et al. Diagnosis and management of chronic graft-versus-host disease. Br J Haematol. 2012;158:46–61.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Klein JP, Barrett AJ, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood. 2002;100:406–414.
   PubMed Web of Science ®Google Scholar
• Saillard C, Crocchiolo R, Furst S, et al. National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen. Leuk Lymphoma. 2014;55:1106–1112.
   PubMed Web of Science ®Google Scholar
• Uhm J, Hamad N, Shin EM, et al. Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014;20:1751–1757.
   PubMedGoogle Scholar
• Cho BS, Lee SE, Song HH, et al. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes. Biol Blood Marrow Transplant. 2012;18:1136–1143.
   PubMed Web of Science ®Google Scholar
• Terwey TH, Le Duc TM, Hemmati PG, et al. NIH-defined graft-versus-host disease and evidence for a potent graft-versus-leukemia effect in patients with acute lymphoblastic leukemia. Ann Oncol. 2013;24:1363–1370.
   PubMed Web of Science ®Google Scholar
• Fiuza-Luces C, Simpson RJ, Ramirez M, et al. Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients. Bone Marrow Transplant. 2016;51:13–26.
   PubMed Web of Science ®Google Scholar
• Krupski C, Jagasia M. Quality of life in the chronic GVHD consortium cohort: lessons learned and the long road ahead. Curr Hematol Malig Rep. 2015;10:183–191.
   PubMed Web of Science ®Google Scholar
• Pidala J, Anasetti C, Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood. 2009;114:7–19.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–956.
   PubMed Web of Science ®Google Scholar
• Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21:389–401 e381.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204–217.
   PubMed Web of Science ®Google Scholar
• Castagna L, Boubdallah R, Furst S, et al. Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT. Bone Marrow Transplant. 2013;48:794–798.
   PubMed Web of Science ®Google Scholar
• Duque-Afonso J, Ihorst G, Wasch R, et al. Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48:1098–1103.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Quality assessment tool for observational cohort and cross-sectional studies [Internet]. Bethesda (MD): American [ cited 2017 Aug 27]. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
   Google Scholar
• Amin EN, Phillips GS, Elder P, et al. Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT. Bone Marrow Transplant. 2015;50:289–295.
   PubMed Web of Science ®Google Scholar
• DePalo J, Chai X, Lee SJ, et al. Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life. Oral Oncol. 2015;51:944–949.
   PubMed Web of Science ®Google Scholar
• Inamoto Y, Martin PJ, Chai X, et al. Clinical benefit of response in chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2012;18:1517–1524.
   PubMed Web of Science ®Google Scholar
• Inamoto Y, Pidala J, Chai X, et al. Assessment of joint and fascia manifestations in chronic graft-versus-host disease. Arthritis Rheumatol. 2014;66:1044–1052.
   PubMed Web of Science ®Google Scholar
• Pidala J, Chai X, Kurland BF, et al. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study. Biol Blood Marrow Transplant. 2013;19:784–791.
   PubMed Web of Science ®Google Scholar
• Pidala J, Chai X, Martin P, et al. Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium. Biol Blood Marrow Transplant. 2013;19:967–972.
   PubMed Web of Science ®Google Scholar
• Pidala J, Kurland BF, Chai X, et al. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the chronic graft-versus-host disease consortium. Haematologica. 2011;96:1528–1535.
   PubMed Web of Science ®Google Scholar
• Pidala J, Vogelsang G, Martin P, et al. Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a chronic graft-versus-host disease consortium study. Haematologica. 2012;97:451–458.
   PubMed Web of Science ®Google Scholar
• Sun YC, Chai X, Inamoto Y, et al. Impact of ocular chronic graft-versus-host disease on quality of life. Biol Blood Marrow Transplant. 2015;21:1687–1691.
   PubMed Web of Science ®Google Scholar
• Wong FL, Francisco L, Togawa K, et al. Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood. 2010;115:2508–2519.
   PubMed Web of Science ®Google Scholar
• El-Jawahri A, Pidala J, Inamoto Y, et al. Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:1341–1348.
   PubMed Web of Science ®Google Scholar
• Baird K, Steinberg SM, Grkovic L, et al. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. Biol Blood Marrow Transplant. 2013;19:632–639.
   PubMed Web of Science ®Google Scholar
• Bassim CW, Fassil H, Dobbin M, et al. Malnutrition in patients with chronic GVHD. Bone Marrow Transplant. 2014;49:1300–1306.
   PubMed Web of Science ®Google Scholar
• Bassim CW, Fassil H, Mays JW, et al. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015;94:547–554.
   PubMed Web of Science ®Google Scholar
• Imanguli MM, Atkinson JC, Mitchell SA, et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant. 2010;16:1362–1369.
   PubMed Web of Science ®Google Scholar
• Martires KJ, Baird K, Steinberg SM, et al. Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood. 2011;118:4250–4257.
   PubMed Web of Science ®Google Scholar
• Mo XD, Xu LP, Liu DH, et al. Health related quality of life among patients with chronic graft-versus-host disease in China. Chin Med J (Engl). 2013;126:3048–3052.
   PubMed Web of Science ®Google Scholar
• Pidala J, Kurland B, Chai X, et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the chronic GVHD consortium. Blood. 2011;117:4651–4657.
   PubMed Web of Science ®Google Scholar